Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of response to etoricoxib in ankylosing spondylitis patients with inadequate response to ≥2 NSAIDs
2009-017309-12Phase 4Completed
- Sponsor
- Fundación Española de Reumatología
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of etoricoxib in ankylosing spondylitis (AS), sponsored by Fundación Española de Reumatología. Primary endpoint: Primary ASASBIO response at week 4. Started Dec 2009; status: completed.
02
Drugs
etoricoxib
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on 2009-017309-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017309-12.